BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
29 hedge funds and large institutions have $7.09M invested in Bellicum Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
74% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 27
Holders
29
Holding in Top 10
–
Calls
$2.41M
Puts
$105K
Top Buyers
| 1 | +$89K | |
| 2 | +$87.6K | |
| 3 | +$77K | |
| 4 |
SCM
Sio Capital Management
New York
|
+$58K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$57.1K |
Top Sellers
| 1 | -$649K | |
| 2 | -$516K | |
| 3 | -$455K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$197K |
| 5 |
Renaissance Technologies
New York
|
-$160K |